摘要
The mechanisms that control B cell terminal differentiation remain undefined. Here, we investigate the role of bromodomain-containing protein 4 (Brd4) in regulating B cell differentiation and its therapeutic potential for B cell-mediated autoimmune diseases including systemic lupus erythematosus (SLE). We showed that Brd4 inhibitor PFI-1 suppressed plasmablast-mediated plasma cell differentiation in healthy human CD19(+) B cells. PFI-1 reduced IgG and IgM secretion in costimulation-induced human B cells. We also observed a reduced percentage of plasma cells in mice with B cell-specific deletion of the Brd4 gene (Brd4(flox/flox)CD19-cre(+)). Mechanistically, using the luciferase reporter assay and the chromatin immunoprecipitation, we explored that Brd4 regulates the expression of B lymphocyte-induced maturation protein 1 (BLIMP1), an important transcript factor that is involved in modulation of plasma cell differentiation. Interestingly, PFI-1 decreased the percentages of plasmablasts and plasma cells from patients with SLE. PFI-1 administration reduced the percentages of plasma cells, hypergammaglobulinemia, and attenuated nephritis in MRL/lpr lupus mice. Pristane-injected Brd4(flox/flox)CD19-cre(+) mice exhibited improved nephritis and reduced percentages of plasma cells. These findings suggest an essential factor of Brd4 in regulating plasma cell differentiation. Brd4 inhibition may be a potential strategy for the treatment of B cell-associated autoimmune disorders.
学科与关键词
- IL-17 sustains the plasma cell response via p38-mediated Bcl-xL RNA stability in lupus pathogenesisMa, Kongyang; Du, Wenhan; Xiao, Fan; Han, Man; Huang, Enyu; Peng, Na; Tang, Yuan; Deng, Chong; Liu, Lixiong; Chen, Yulan; Li, Jingjing; Yuan, Shiwen; Huang, Qin; Hong, Xiaoping; Hu, Dajun; Cai, Xiaoyan; Jiang, Quan; Liu, Dongzhou; Lu, Liwei*Cellular & Molecular Immunology, 2021, 18(7): 1739-1750.被引 20
- Ophiopogonin D attenuates the progression of murine systemic lupus erythematosus by reducing B cell numbersNie, Yingkun*; Li, Chunyan; Sun, NiJOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2023, 37(7).
- SMURF1 inhibits the Th17 and Th17.1 polarization and improves the Treg/ Th17 imbalance in systemic lupus erythematosus through the ubiquitination of ROR gamma tZhong, Wei; Feng, Leheng; Tian, Wei; Qu, Hongbo; Xu, Haibo; Ning, Ke; Liu, Li; Liu, Wei; Gong, Xiaowei; Chen, Hong*Molecular Immunology, 2023, 157: 186-194.
